Nonetheless, our findings support the notion that the SOCS1-mediated downregulation of NFE2L2 expression likely impacts at least a subset of NRF2 target genes such as GCLC in HCC. This evidence concerns the gene NFE2L2 and hepatocellular carcinoma.